As per the latest market research conducted by FMI, the global radiotherapy patient positioning accessories market is expected to record a CAGR of 4.8% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 619.5 million. By 2033, the valuation is anticipated to reach US$ 993.6 million.
Radiotherapy patient positioning accessories are the tools used to accurately position and immobilize patients undergoing radiation therapy. These positioning accessories help to ensure that the radiation dose is delivered precisely to the tumor, while also protecting healthy tissue from damage.
Significant Growth Aspects:
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The radiotherapy patient positioning accessories market is expected to experience a healthy growth rate in the coming years. However, there are certain factors that can impede this growth and limit the potential of the market. These factors include the high cost of radiotherapy equipment, lack of skilled professionals, and stringent government regulations. Also, the lack of awareness among healthcare personnel about the latest advancements in radiotherapy technology can also restrain the market growth.
Attributes | Value |
---|---|
Radiotherapy Patient Positioning Accessories Value (2022) | US$ 588.8 million |
Radiotherapy Patient Positioning Accessories Market Expected Value (2023) | US$ 619.5 million |
Radiotherapy Patient Positioning Accessories Market Forecast Value (2033) | US$ 993.6 million |
Radiotherapy Patient Positioning Accessories Market Expected CAGR (2023 to 2033) | 4.8% |
Particulars | Details |
---|---|
H1, 2021 | 4.95% |
H1, 2022 Projected | 5.09% |
H1, 2022 Outlook | 4.99% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
BPS Change - H1, 2022 (O) - H1, 2021 | (+) 04 ↑ |
The global radiotherapy patient positioning accessories market is subject to market dynamics associated with macroeconomic and industry standards such as regulatory guidelines and product quality and safety assessment.
According to Future Market Insights' analysis, the global radiotherapy patient positioning accessories market expects to surge in value by 04 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to the H1-2022 Projected value, the market during the H1-2022 outlook period showed a dip of 10 BPS.
The growth of intensity-modulated radiation treatment, stereotactic body radiotherapy, and adaptive radiotherapy has resulted in an increase in the necessity for effective patient positioning, which is correlated with an increase in the observed BPS values.
The usage of immobilization devices during radiation for improved procedural outcomes is one of the significant industry breakthroughs.
However, as a result of the global lockdown measures implemented during the COVID-19 pandemic's onset, the reported reduction in BPS is linked to a relative decline in medical diagnostic and imaging operations. Hence, lower procedure rates have helped to bring down BPS levels.
The demand in the global radiotherapy patient positioning accessories market recorded a CAGR of 4.6% from 2018 to 2022. The sales of radiotherapy patient positioning accessories are estimated to grow by 1.6x between 2023 and 2033, reveals FMI.
A non-invasive cancer treatment method known as radiation therapy employs high-intensity waves or particles to eliminate cancerous cells. Radiation patient positioning accessories are widely used to help patients keep their position comfortably since it is important for patients to retain their specific position during therapy to avoid issues. This is helping the market to expand.
Due to radiation therapy's fewer side effects and capacity to stop the regrowth of cancer cells, more and more people are switching from various cancer therapies like chemotherapy and surgery. This is driving up demand for equipment for patient positioning during radiation.
As per the latest market research conducted by FMI, the global radiotherapy patient positioning accessories market is expected to record a CAGR of 4.8% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 619.5 million. By 2033, the valuation is anticipated to reach US$ 993.6 million.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
A major growth in the burden of cancer is being noticed over the previous few years, mainly to the growing alcohol intake, smoking, and others. For instance, the World Health Organization (WHO) estimates that more than 10 million new instances of cancer would be diagnosed worldwide in 2020.
To reduce the incidence and cancer-related deaths, governments in many nations are increasingly launching several cancer detection and treatment efforts. In order to encourage early cancer diagnosis, the Government of India announced the formation of the National Programme for Prevention & Control of Cancer, Diabetes, Cardiovascular diseases & Stroke (NPCDCS).
Many such initiatives in the United States, Germany, the United Kingdom, and China have significantly raised the rate of cancer diagnoses, spurring a rise in the use of cutting-edge cancer therapies like radiation. In the upcoming years, there is likely to be a high need for accessories for radiotherapy patient positioning as a result of this.
To Increase Sales of Radiotherapy Immobilization Devices, Patients' Preferences are being Shifted Towards Non-Invasive Treatments.
By 2033, the United Kingdom is anticipated to contribute significantly to sales in the Europe market, according to FMI, and is predicted to record a CAGR of 4.2% over the forecast period.
Due to its non-invasive nature and lack of side effects when compared to other therapies, advanced cancer treatments like radiation are becoming extremely popular throughout the United Kingdom, hence it is predicted that rising rates of obesity, smoking, alcoholism, nicotine addiction, and cancer is likely to increase demand for radiation immobilization tools such as locating & indexing bars, couch top & overlays, and others.
Favorable Government Early Diagnose Efforts to Drive Demand for Radiotherapy Patient Positioning Accessories
FMI estimates that the United States is likely to continue dominating the North American radiotherapy patient positioning accessories market over the forecast period. The market in the United States is expected to record a CAGR of 4.2% over the forecast period.
The government in the countries is launching several programs to reduce the fatalities brought on by cancer, such as putting up free screening camps, in response to the rising incidence of cancer and increasing awareness of the advantages of an early cancer diagnosis. Due to this, there is a sharp increase in demand for radiation patient positioning accessories across the nation's installed base of radiotherapy systems.
Growth Outlook of Country-wise Insights:
Country | United States |
---|---|
CAGR (2018 to 2022) | 4.3% |
CAGR (2023 to 2033) | 4.2% |
Valuation (2033) | US$ 273.7 million |
Country | United Kingdom |
---|---|
CAGR (2018 to 2022) | 4.4% |
CAGR (2023 to 2033) | 4.2% |
Valuation (2033) | US$ 39.9 million |
Country | China |
---|---|
CAGR (2018 to 2022) | 7.9% |
CAGR (2023 to 2033) | 9.3% |
Valuation (2033) | US$ 94.6 million |
Country | Germany |
---|---|
CAGR (2018 to 2022) | 5.4% |
CAGR (2023 to 2033) | 5.1% |
Valuation (2033) | US$ 53.4 million |
Increasing Two-Step Radiation Treatment Adoption to Meet Need for Radiotherapy Patient Positioning Accessories
By 2023, sales of radiotherapy patient positioning accessories are expected to be dominated by the couch tops & overlays category, with more than 1/5 of the market, according to Future Market Insights.
In two-step radiation therapy, couch tops & overlays are frequently employed in diagnosis and imaging equipment, such as CT scans, to let patients relax in a specific position comfortably. As a result, the segment is growing because of the increasing use of two-step radiation therapy for accurately targeting malignant areas.
Increasing Medical Travel to Boost Sales of Radiation Treatment Immobilization Equipment
On the basis of end user, the global radiotherapy patient positioning accessories market is segmented into hospitals, radiation/proton therapy centers, and cancer research institutes. FMI states that the hospital segment is estimated to record a CAGR of 3.9% over the forecast period.
Radiation therapy immobilization device sales are being supported by rising medical tourism, which is increasing patient volume in cancer treatment centers. The segment's expansion is primarily facilitated by the presence of competent professionals, cutting-edge cancer diagnosis and treatment technology, and benevolent reimbursement policies in hospitals.
Leading companies in the global market for radiotherapy patient positioning accessories are utilizing inorganic tactics and forming strategic alliances, partnerships, mergers, and acquisitions with other market participants to broaden their reach internationally. For example,
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | US$ million for Value |
Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa |
Key Countries Covered | United States, Canada, Germany, United Kingdom, France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Türkiye, Northern Africa, South Africa |
Key Segments Covered | Product Type, End User, and Region |
Key Companies Profiled |
|
Report Coverage | Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
The market is projected to secure a valuation of US$ 619.5 million in 2023.
From 2018 to 2022, the market registered a CAGR of 4.6%.
The market is expected to reach US$ 993.6 million in 2033.
Shift in patients' preferences toward non-invasive treatments fueling the United Kingdom Market.
CDR Systems, CIVCO Radiation, Orfit Industries N.V. are the leading industry players.
1. Executive Summary | Radiotherapy Patient Positioning Accessories Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Couch Tops & Overlays 5.3.1.1. Couch Top with Moving Rails 5.3.1.2. Couch Tops without Moving Rails 5.3.1.3. Inserts 5.3.1.4. CT Overlays 5.3.1.5. MR Overlays 5.3.2. Thermoplastic Masks & Sheets 5.3.2.1. Head Masks 5.3.2.2. Head and Shoulder Masks 5.3.2.3. Breast and Pelvic Sheets 5.3.3. Markers 5.3.3.1. Fiducial Markers 5.3.3.2. Vaginal Markers 5.3.3.3. Rectal Markers 5.3.4. Immobilization System 5.3.5. Head Rest 5.3.6. Cushions 5.3.7. Spacers & Wedges 5.3.8. Arm & Wrist Supports 5.3.9. Locating & Indexing Bar 5.3.10. Safety drapes 5.3.11. Boot pads 5.3.12. Other products 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Surgeries 6.3.2. Diagnostic & Imaging 6.3.3. Cancer Therapy 6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033 7.3.1. Hospitals 7.3.2. Radiation/Proton Therapy Centres 7.3.3. Cancer Research Institutes 7.3.4. Ambulatory Surgical Centres 7.3.5. Speciality Clinics 7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Product 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Product 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Product 14.2.3. By Application 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Application 14.3.4. By End User 14.4. Key Takeaways 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product 15.2.3. By Application 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Application 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product 16.1.2.2. By Application 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product 16.2.2.2. By Application 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product 16.3.2.2. By Application 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product 16.4.2.2. By Application 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product 16.5.2.2. By Application 16.5.2.3. By End User 16.6. United Kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product 16.6.2.2. By Application 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product 16.7.2.2. By Application 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product 16.8.2.2. By Application 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product 16.9.2.2. By Application 16.9.2.3. By End User 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product 16.10.2.2. By Application 16.10.2.3. By End User 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product 16.11.2.2. By Application 16.11.2.3. By End User 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product 16.12.2.2. By Application 16.12.2.3. By End User 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product 16.13.2.2. By Application 16.13.2.3. By End User 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product 16.14.2.2. By Application 16.14.2.3. By End User 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product 16.15.2.2. By Application 16.15.2.3. By End User 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product 16.16.2.2. By Application 16.16.2.3. By End User 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product 16.17.2.2. By Application 16.17.2.3. By End User 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product 16.18.2.2. By Application 16.18.2.3. By End User 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product 16.19.2.2. By Application 16.19.2.3. By End User 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product 16.20.2.2. By Application 16.20.2.3. By End User 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product 16.21.2.2. By Application 16.21.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product 17.3.3. By Application 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Bionix Radiation Therapy 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. CDR Systems 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. CIVCO Radiation 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Orfit Industries N.V. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. IZI Medical Products 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Klarity Medical Products 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Best Medical International Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Eckert & Ziegler BEBIG 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Qfix 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Elekta AB 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports